REVAXIS susp inj av 1 aiguille ser pré 0.5 ml
7680006460034
CH-646
J07CA01
08.08.
1 / 3
google
Details
- Product number
- 0064601
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- toxoidum tetani min. 20 U.I., toxoidum diphtheriae min. 2 U.I., virus poliomyelitis typus 1 inactivatus 29 U., virus poliomyelitis typus 2 inactivatus 7 U., virus poliomyelitis typus 3 inactivatus 26 U., aluminium 0.35 mg ut aluminii hydroxidum hydricum ad adsorptionem, formaldehydum, medium 199 cum phenylalaninum 12.5 µg, phenoxyethanolum, ethanolum anhydricum 2 mg, acidum hydrochloridum, natrii hydroxidum, acidum aceticum, aqua ad iniectabile, ad suspensionem pro 0.5 ml corresp., kalium 0.12 mg et natrium 1.6 mg, residui: neomycinum, streptomycinum, polymyxinum B.
Articles (1)
Revaxis, suspension injectable
Injektionssuspension
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
- | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
29.0 U | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
7.0 U | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
26.0 U | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
0.35 MG | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
12.5 UG | Substance | HBESI |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
2.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.12 MG | Substance | HBESI |
|
(N/A)
|
1.6 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HIMDK |
|
(N/A)
|
- | Substance | HIMDK |
|
(N/A)
|
- | Substance | HIMDK |
Reimbursement information
Public price
CHF 29.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/04/2001
Authorization holder
Sanofi-Aventis (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 646
- Drug name
- Revaxis, suspension injectable
- Galenic form
- SUPA
- ATC Code
- J07CA01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 10/08/2000
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- REVAXIS susp inj av 1 aiguille ser pré 0.5 ml
- Description (DE)
- REVAXIS Inj Susp mit 1 Nadel Fertspr 0.5 ml
- Market launch
- 10/08/2000
- Narcotic (BTM)
- No
Application methods
SUBC
IMU